Search
Evogene Ltd
EVGNAdd to Watchlist
0.375USD
-0.005-1.32%
Close 10-30 16:00（ET）
5.10MMarket Cap
LossP/E TTM
Today
-1.32%
5 Days
+3.02%
1 Month
-5.54%
6 Months
-51.92%
Year to Date
-65.91%
1 Year
-70.24%
Key Figures
0.378Open
0.380High
638.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
0.380Prev. Close
0.365Low
242.44Turnover
LossP/E Static
-32.28P/B
0.00%Div Yield TTM
-45.06%ROA
1.28052wk High
0.04Volume Ratio
-16.48MNet Profit
13.59MShares
-1.0776EPS TTM
1.36Beta
-482.60%ROE
0.34552wk Low
5.53%Amplitude
50.66%Gross Margin
5.10MMarket Cap
2.12Reward/Risk
4.94%Risk Rate
Evogene Ltd's Score
0.16vs previous score
Forecast8.00
Financial Health6.69
Technical4.43
Valuation Dimensions9.37
Institutional Confidence3.00
Risk Assessment2.16
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Evogene Ltd Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Evogene Ltd Latest Earnings Call Transcripts
Evogene (EVGN) Q2 2026 Earnings Call: Loss Narrows as ChemPass AI Expands
Evogene’s Q2 2026 net loss narrowed 62% to $1.8 million as ChemPass AI collaborations reached six. Management maintained $8.5–$9.5 million cash-use guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.14/-0.27
Revenue / Forecast
347.00K/325.00K
Evogene Ltd Profile
SectorBiotechnology & Medical Research
Ticker SymbolEVGN
Number of employees117
CountryIsrael
Ownership
| Shareholders | Proportion |
|---|---|
| Citadel Advisors LLC | 1.02% |
| Recanati (Leon Yehuda) | 0.96% |
| XTX Markets LLC | 0.26% |
| Jane Street Capital, L.L.C. | 0.21% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 1.02% |
| Individual Investor | 0.96% |
| Research Firm | 0.66% |
| Venture Capital | 0.26% |
Related Instruments
+3.19%
-0.73%
+1.41%
+2.18%
-0.19%
+7.02%
+1.15%
+3.06%
+2.20%
+1.90%
+3.50%
+1.78%
+1.40%
+2.81%
+1.71%
+13.33%
-0.47%
+4.50%
-0.24%
-0.55%Popular Instruments
51788.900
-548.500 (-1.05%)
28406.600
-658.400 (-2.27%)
7583.100
-92.600 (-1.21%)
12785.000
-56.000 (-0.44%)
62328.000
-1656.000 (-2.59%)
6120.900
-77.700 (-1.25%)
102.428
+0.026 (+0.03%)
344.630
-4.280 (-1.23%)
204.640
-9.020 (-4.22%)
3874.710
-146.240 (-3.64%)
FAQs
What is the current price of Evogene Ltd (EVGN)?
The current price of Evogene Ltd (EVGN) is 0.38.
What is the symbol of Evogene Ltd?
The ticker symbol of Evogene Ltd is EVGN.
What is the 52-week high of Evogene Ltd?
The 52-week high of Evogene Ltd is 1.28.
What is the 52-week low of Evogene Ltd?
The 52-week low of Evogene Ltd is 0.34.
What is the market capitalization of Evogene Ltd?
The market capitalization of Evogene Ltd is 5.10M.
Is Evogene Ltd (EVGN) currently rated as Buy, Hold, or Sell?
According to analysts, Evogene Ltd (EVGN) has an overall rating of Buy, with a price target of 2.15.
What is the Earnings Per Share (EPS TTM) of Evogene Ltd (EVGN)?
The Earnings Per Share (EPS TTM) of Evogene Ltd (EVGN) is -1.08.